Disclosed positions

Estimated from their latest filings — positions may have changed since

$2.43M

combined est. value

Stock	Shares	Price	Value	Weight	As of
SNDXSyndax Pharmaceuticals Inc	103,000	$23.61	$2.43M	100%	2026-02-04

SNDX

Syndax Pharmaceuticals Inc

$2.43M

103,000 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 1

Stock	Transaction	Date	~6mo later
SNDXSyndax Pharmaceuticals Inc	Grant — · 24,000 sh	2026-02-04	—
MRSNMersana Therapeutics, Inc.	Other — · 9,573 sh	2026-01-06	—
MRSNMersana Therapeutics, Inc.	Sell $14.7K · 2,012 sh	2025-09-12	—
MRSNMersana Therapeutics, Inc.	Exercise — · 6,670 sh	2025-09-11	—

SNDXGrant

2026-02-04 · Syndax Pharmaceuticals Inc

24,000

—

MRSNOther

2026-01-06 · Mersana Therapeutics, Inc.

9,573

—

MRSNSell

2025-09-12 · Mersana Therapeutics, Inc.

$14.7K

—

MRSNExercise

2025-09-11 · Mersana Therapeutics, Inc.

6,670

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.